BivalirudinCardiovascularSafety Rating 9/10
Primary research areaAnticoagulation in PCI
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range0.75 mg/kg bolus then 1.75 mg/kg/h infusion
AdministrationIntravenous
Safety9/10 · FDA-approved (Angiomax)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Bivalirudin
Mechanism of action
Direct thrombin inhibitor hirudin analog; binds both free and clot-bound thrombin reversibly
Safety profile
Bleeding, back pain, hypotension, bradycardia · Extensive clinical use; predictable pharmacokinetics; manageable bleeding risk
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Bivalirudin below your target.
Related pages